Radiation therapy
1 – 10 of 294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
Persson, Astrid E. LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2026)
In Radiotherapy and Oncology
215.
- Contribution to journal › Article
-
Mark
Medication-defined scoring of urinary toxicity: an ongoing survey and agreement analysis on practices in ultra-hypofractionation trials in prostate cancer
Persson, Astrid E. LU
; Schmidt-Hegemann, Nina-Sophie
and Draulans, Cédric
(2026)
13th Øresund Workshop on Radiotherapy
- Contribution to conference › Poster
-
Mark
Selection of the Most Appropriate Radiation Treatment Modality for Children's Cancers : A Paediatric Radiation Oncology Society (PROS) Position Paper on the Ethical Utilization of Proton Therapy
- Contribution to journal › Article
-
Mark
Ultrahypofraktionerad strålbehandling vid lokaliserad prostatacancer i klinisk vardag: en kohortbeskrivning från Skånes universitetssjukhus
Persson, Astrid E. LU
; Kjellén, Elisabeth
LU
; Ståhl, Olof
; Adrian, Gabriel
LU
; Scherman, Jonas
; Stattin, Pär
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2026)
Onkologidagarna 2026
- Contribution to conference › Poster
-
Mark
Fractionation gives therapeutic benefit in animal model of [177Lu]Lu-PSMA-617 therapy of prostate cancer
Timmermand, Oskar Vilhelmsson LU
; Östholm, Axel
LU
; Zedan, Wahed
LU
; Strand, Joanna
LU
; Altai, Mohamed
LU
and Örbom, Anders
LU
(2026)
In EJNMMI Research
16.
p.1-7
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC) : 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial
Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Beckman, Lars
; Widmark, Anders
; Fransson, Per
; Hoyer, Morten
; Lagerlund, Magnus
; Kindblom, Jon
; Johansson, Bengt
and Björnlinger, Kirsten
, et al.
(2026)
In The Lancet. Oncology
27(3).
p.293-301
- Contribution to journal › Article
-
Mark
Not All Tumors Are Alike : Varying Efficacy of FLASH Across Tumor Types and Oxygenation Status in Spheroid Models
Dela, Rebecka LU ; Lemos Da Silva, Liliana LU
; Beyer, Sarah
LU
; Sørensen, Brita Singers
; Poulsen, Per
; Konradsson, Elise
LU
; Hörberger, Filip
LU
; Petersson, Kristoffer
LU
; Ceberg, Crister
LU
and Adrian, Gabriel
LU
(2026)
In The British journal of radiology
99(1177).
p.65-72
- Contribution to journal › Article
-
Mark
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma—Are We Ready to Individualize Treatment?
Gebre-Medhin, Maria LU and Adrian, Gabriel LU
(2026)
In International Journal of Radiation Oncology Biology Physics
124(3).
p.686-691
- Contribution to journal › Debate/Note/Editorial
-
Mark
Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model
Ghita-Pettigrew, Mihaela ; Brown, Kathryn H. ; Kerr, Brianna N. ; Walls, Gerard M. ; Verginadis, Ioannis I. ; Adrian, Gabriel LU
; Petersson, Kristoffer
LU
; McMahon, Stephen J.
and Butterworth, Karl T.
(2026)
In Radiotherapy and Oncology
216.
- Contribution to journal › Article
-
Mark
Carcinoma of the parotid Gland : A Population-Based study of incidence and treatment outcomes in 1018 patients
- Contribution to journal › Article